TSXV - Delayed Quote • CAD
Quest PharmaTech Inc. (QPT.V)
At close: April 19 at 3:59 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Ragupathy Madiyalakan Ph.D. | CEO & Director | 215k | -- | -- |
Mr. Pierre Vermette C.A., CPA | Chief Financial Officer | 74.17k | -- | -- |
Mr. Roger Andrews | Head of Investor Relations & Corporate Communications | -- | -- | -- |
Mr. Douglas C. Bachman | Vice President of Corporate Development | 37.94k | -- | 1954 |
Mr. Thomas Woo | Vice President of Product Development | -- | -- | -- |
Quest PharmaTech Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Corporate Governance
Quest PharmaTech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jul 21, 2005Ex-Dividend Date
Upcoming Events
Upcoming Events Information Not Available